International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3, Supplement , Page A14, 1 November 2009

Continuing Medical Education

Article Outline

 

Back to Article Outline

Physicians 

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ASTRO designates this educational activity for a maximum of 39.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Back to Article Outline

Physicists 

Application will be submitted to the Commission on Accreditation of Medical Physics Education Program for CAMPEP credit.

Back to Article Outline

Technologists 

Application will be submitted to the American Society for Radiologic Technologists for designation of Category A continuing education credit.

Back to Article Outline

Dosimetrists 

Application will be submitted to the Medical Dosimetrist Certification Board for designation of MDCB credit.

Back to Article Outline

Nurses 

The Oncology Nursing Society (ONS) is accredited as an approver of continuing education for nurses by the American Nurses Credentialing Center's Commission on Accreditation. Application will be submitted to ONS for designation of CEU credit.

Back to Article Outline

Disclosure of Vested Interest 

Presenters have been asked to disclose the existence of any financial or other relationship they have with the manufacturer(s) or any commercial product(s) or provider(s) of any commercial services discussed in the presentation. This disclosure information is noted at the end of each abstract. Presenters should also announce their disclosure information to the audience at the beginning of their presentation and in accordance with ACCME standards.

Back to Article Outline

Off-Label Use 

ASTRO's scientific program may include presentations on drugs or devices, or uses of drugs or devices, which may not have been approved by the FDA or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. Please refer to the official prescribing information for approved indications, contraindications and warnings.

Back to Article Outline

Disclaimer 

ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented.

Information included in this publication is current as of August 30, 2009 and is subject to change.

PII: S0360-3016(09)01058-X

doi:10.1016/j.ijrobp.2009.07.016

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3, Supplement , Page A14, 1 November 2009